Drawing for BYFAVO

USPTO serial 88817162

BYFAVO

Reviewed by CopyMark Law Group

Reg. 6342995Status 702Renewal
Filing date
Status date
Registration date
May 4, 2021
Examiner
CANTOR, JILLIAN REDDING
Law office
Historical data usage

What this means

This registration is in, or will soon enter, a USPTO maintenance window. Missing a Section 8 or Section 9 filing can cancel the registration.

Status 702: Status 702 means the registration is active, Section 8 was accepted, and a Section 15 declaration of incontestability was also accepted. Incontestability strengthens your rights by limiting certain challenges after five years of continuous use.

Need help with BYFAVO?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Get help with this Renewal, set up monitoring, or talk with CopyMark.
Get Attorney Assistance for just $399*

Plus Government fees of $325

Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

John M. Mueller

John M. Mueller BAKER & HOSTETLER LLP312 Walnut StreetSuite 3200Cincinnati, OH 45202-4074

Goods and services

ClassDescriptionStatusFirst use
005pharmaceutical preparations for use in sedation, general sedation, procedural sedation, intensive care medicine sedation, moderate sedation and conscious sedation; sedatives; pharmaceutical preparations to facilitate sedation or anesthesia for dental surgery; pharmaceutical preparations to facilitate sedation for colonoscopy, bronchoscopy and gastroenterological procedures; pharmaceutical sedative preparations for use in the field of sedation or anesthesia in intensive care medicine; pharmaceutical preparations for use for sedation and anesthesia in the fields of cardiology, radiology, vascular surgery, emergency medicine, outpatient surgeries, dermatology, plastic surgery and orthopaedics; pharmaceutical preparations for use for sedation and anesthesia in the diagnosis or treatment of skin and soft tissue injuries or disorders; pharmaceutical preparations for use for sedation and anesthesia in surgical procedures of the skin and soft tissue; pharmaceutical preparations for the induction of sedation, anxiety relief, and pain relief during therapeutic and diagnostic procedures; pharmaceutical preparations for the induction of sedation, anxiety relief, and pain relief during surgery; pharmaceutical sedative and anesthetic preparations for use in colonoscopy, bronchoscopy and gastroenterological procedures; pharmaceutical sedative and anesthetic preparations for use in endoscopy, colonoscopy, sigmoidoscopy, anoscopy, rectoscopy and proctoscopy; pharmaceutical sedative and anesthetic preparations for use in surgical procedures; pharmaceutical sedative and anesthetic preparations for use in the following procedures: cardiac catherization, interventional radiology, endovascular procedures, peripheral angioplasty, cardiac defibrillator, implantation of peripheral stents and pacemakers, adjustment of peripheral stents and pacemakers, removal of peripheral stents and pacemakers, dermatologic procedures and oral surgeryACTIVE—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Aug 14, 2026NA85NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED—
Aug 14, 2026C15AREGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.—
Aug 14, 2026APRECASE ASSIGNED TO POST REGISTRATION PARALEGAL—
May 11, 2026E815TEAS SECTION 8 & 15 RECEIVED—
May 4, 2026REM1COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED—
Jul 28, 2023TCCATEAS CHANGE OF CORRESPONDENCE RECEIVED—
Jul 28, 2023ECDRTEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS—
Jul 28, 2023ARAAATTORNEY/DOM.REP.REVOKED AND/OR APPOINTEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Jul 28, 2023REAPTEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED—
Aug 5, 2022TCCATEAS CHANGE OF CORRESPONDENCE RECEIVED—
Aug 5, 2022ECDRTEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS—
Aug 5, 2022ARAAATTORNEY/DOM.REP.REVOKED AND/OR APPOINTEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Aug 5, 2022REAPTEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED—
Jun 1, 2021TCCATEAS CHANGE OF CORRESPONDENCE RECEIVED—
Jun 1, 2021ECDRTEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS—
Jun 1, 2021EWAFTEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS—
Jun 1, 2021ARAAATTORNEY/DOM.REP.REVOKED AND/OR APPOINTEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Jun 1, 2021REAPTEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED—
May 4, 2021R.PRREGISTERED-PRINCIPAL REGISTERYour trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive.
Mar 30, 2021SUNANOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED—
Mar 29, 2021CNPRALLOWED PRINCIPAL REGISTER - SOU ACCEPTED—
Mar 16, 2021EXRANOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED—
Mar 15, 2021SUPCSTATEMENT OF USE PROCESSING COMPLETE—
Mar 15, 2021EX1GSOU EXTENSION 1 GRANTED—
Mar 15, 2021AITUCASE ASSIGNED TO INTENT TO USE PARALEGAL—
Feb 25, 2021IUAFUSE AMENDMENT FILED—
Feb 25, 2021EXT1SOU EXTENSION 1 FILED—
Feb 25, 2021EEXTSOU TEAS EXTENSION RECEIVEDThe applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use.
Feb 25, 2021EISUTEAS STATEMENT OF USE RECEIVEDThe applicant filed a Statement of Use with specimens showing the mark in actual commerce. The USPTO will review the filing for compliance. If accepted, the mark can proceed to registration; if deficient, the USPTO may issue a requirement or office action.
Feb 22, 2021CHANAPPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED—
Feb 22, 2021TCCATEAS CHANGE OF CORRESPONDENCE RECEIVED—
Feb 22, 2021ECDRTEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS—
Feb 22, 2021ARAAATTORNEY/DOM.REP.REVOKED AND/OR APPOINTEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Feb 22, 2021REAPTEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED—
Feb 22, 2021COARTEAS CHANGE OF OWNER ADDRESS RECEIVED—
Feb 17, 2021ASGNAUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP—
Aug 25, 2020NOAMNOA E-MAILED - SOU REQUIRED FROM APPLICANTA Notice of Allowance means your intent-to-use application cleared examination and opposition but is not registered yet. You must file a Statement of Use showing the mark in commerce, or request an extension, before the deadline — usually six months from the notice date.
Jun 30, 2020NPUBOFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED—
Jun 30, 2020PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Jun 10, 2020NONPNOTIFICATION OF NOTICE OF PUBLICATION E-MAILED—
May 27, 2020ALIEASSIGNED TO LIE—
May 20, 2020CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
May 20, 2020XAECEXAMINER'S AMENDMENT ENTERED—
May 20, 2020GNENNOTIFICATION OF EXAMINERS AMENDMENT E-MAILED—
May 20, 2020GNEAEXAMINERS AMENDMENT E-MAILED—
May 20, 2020CNEAEXAMINERS AMENDMENT -WRITTEN—
May 20, 2020DOCKASSIGNED TO EXAMINER—
Mar 8, 2020NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
Mar 5, 2020NWAPNEW APPLICATION ENTERED—

Frequently asked questions

Related guidance